Farallon Capital Management as of June 30, 2019
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 98 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Altaba | 16.3 | $2.0B | 28M | 69.37 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 8.9 | $1.1B | 3.6M | 293.00 | |
Anadarko Petroleum Corporation | 6.1 | $738M | 11M | 70.56 | |
Wabtec Corporation (WAB) | 3.9 | $471M | 6.6M | 71.76 | |
Iqvia Holdings (IQV) | 3.4 | $415M | 2.6M | 160.90 | |
Array BioPharma | 3.3 | $394M | 8.5M | 46.33 | |
Fidelity National Information Services (FIS) | 2.9 | $349M | 2.8M | 122.68 | |
Anthem (ELV) | 2.5 | $296M | 1.1M | 282.21 | |
Charter Communications Inc N Cl A (CHTR) | 2.3 | $277M | 700k | 395.18 | |
General Dynamics Corporation (GD) | 2.0 | $243M | 1.3M | 181.82 | |
Playa Hotels & Resorts Nv SHS (PLYA) | 2.0 | $236M | 31M | 7.71 | |
Ihs Markit SHS | 1.9 | $230M | 3.6M | 63.72 | |
Sherwin-Williams Company (SHW) | 1.8 | $213M | 466k | 458.29 | |
Visa Com Cl A (V) | 1.7 | $206M | 1.2M | 173.55 | |
Equifax (EFX) | 1.6 | $198M | 1.5M | 135.24 | |
Equinix (EQIX) | 1.6 | $193M | 383k | 504.29 | |
S&p Global (SPGI) | 1.6 | $192M | 841k | 227.79 | |
Citrix Systems | 1.6 | $188M | 1.9M | 98.14 | |
Booking Holdings (BKNG) | 1.5 | $183M | 97k | 1874.71 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 1.5 | $177M | 1.5M | 115.15 | |
Facebook Cl A (META) | 1.4 | $175M | 904k | 193.00 | |
Astrazeneca Sponsored Adr (AZN) | 1.4 | $169M | 4.1M | 41.28 | |
Microsoft Corporation (MSFT) | 1.4 | $169M | 1.3M | 133.96 | |
Cigna Corp (CI) | 1.4 | $165M | 1.1M | 157.55 | |
Alphabet Cap Stk Cl C (GOOG) | 1.3 | $154M | 142k | 1080.91 | |
Iovance Biotherapeutics (IOVA) | 1.2 | $140M | 5.7M | 24.52 | |
Transunion (TRU) | 1.0 | $123M | 1.7M | 73.51 | |
Sea Sponsored Ads (SE) | 0.9 | $112M | 3.4M | 33.22 | |
Mirati Therapeutics | 0.8 | $103M | 995k | 103.00 | |
Myokardia | 0.8 | $100M | 2.0M | 50.14 | |
Acceleron Pharma | 0.8 | $98M | 2.4M | 41.08 | |
Liberty Global SHS CL C | 0.8 | $98M | 3.7M | 26.53 | |
Zogenix Com New | 0.8 | $96M | 2.0M | 47.78 | |
Zayo Group Hldgs | 0.8 | $93M | 2.8M | 32.91 | |
Sage Therapeutics (SAGE) | 0.8 | $92M | 500k | 183.09 | |
Alibaba Group Hldg Sponsored Ads (BABA) | 0.7 | $85M | 500k | 169.45 | |
Amarin Corp Spons Adr New (AMRN) | 0.7 | $82M | 4.3M | 19.39 | |
Enanta Pharmaceuticals (ENTA) | 0.7 | $81M | 960k | 84.38 | |
Alnylam Pharmaceuticals (ALNY) | 0.7 | $80M | 1.1M | 72.56 | |
Genesee & Wyo Cl A | 0.6 | $78M | 775k | 100.00 | |
Fibrogen (FGEN) | 0.6 | $77M | 1.7M | 45.18 | |
Sarepta Therapeutics (SRPT) | 0.6 | $76M | 500k | 151.95 | |
Novocure Ord Shs (NVCR) | 0.6 | $76M | 1.2M | 63.23 | |
Reata Pharmaceuticals Cl A | 0.6 | $76M | 800k | 94.35 | |
Sprint | 0.6 | $70M | 11M | 6.57 | |
Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.5 | $65M | 3.1M | 21.10 | |
Exelixis (EXEL) | 0.5 | $64M | 3.0M | 21.37 | |
Global Blood Therapeutics In | 0.5 | $59M | 1.1M | 52.60 | |
Liberty Global Shs Cl A | 0.5 | $56M | 2.1M | 26.99 | |
Arrowhead Pharmaceuticals (ARWR) | 0.4 | $53M | 2.0M | 26.50 | |
Fate Therapeutics (FATE) | 0.4 | $51M | 2.5M | 20.30 | |
Radius Health Com New | 0.4 | $50M | 2.0M | 24.36 | |
CVS Caremark Corporation (CVS) | 0.4 | $45M | 823k | 54.49 | |
Fox Corp Cl B Com (FOX) | 0.4 | $43M | 1.2M | 36.53 | |
Nxp Semiconductors N V (NXPI) | 0.3 | $42M | 430k | 97.61 | |
Zymeworks | 0.3 | $39M | 1.8M | 22.00 | |
First Data Corp Com Cl A | 0.3 | $39M | 1.4M | 27.07 | |
Progenics Pharmaceuticals | 0.3 | $34M | 5.5M | 6.17 | |
Ready Cap Corp Com reit (RC) | 0.3 | $33M | 2.2M | 14.90 | |
Metropcs Communications (TMUS) | 0.3 | $32M | 426k | 74.14 | |
Fox Corp Cl A Com (FOXA) | 0.3 | $31M | 836k | 36.64 | |
Ptc Therapeutics I (PTCT) | 0.2 | $27M | 600k | 45.00 | |
Ptc Therapeutics Note 3.000% 8/1 (Principal) | 0.2 | $27M | 24M | 1.11 | |
Crispr Therapeutics Namen Akt (CRSP) | 0.2 | $24M | 500k | 47.10 | |
Quotient SHS | 0.2 | $23M | 2.5M | 9.35 | |
Codexis (CDXS) | 0.2 | $23M | 1.3M | 18.43 | |
D Stemline Therapeutics | 0.2 | $23M | 1.5M | 15.32 | |
Sina Corp Ord | 0.2 | $22M | 510k | 43.13 | |
Zealand Pharma A S Sponsored Adr | 0.2 | $22M | 1.0M | 21.55 | |
Invitae (NVTAQ) | 0.2 | $21M | 900k | 23.50 | |
Cara Therapeutics (CARA) | 0.2 | $21M | 951k | 21.50 | |
Voyager Therapeutics (VYGR) | 0.2 | $20M | 750k | 27.22 | |
Chemocentryx | 0.2 | $19M | 2.0M | 9.30 | |
Protagonist Therapeutics (PTGX) | 0.2 | $18M | 1.5M | 12.11 | |
Avrobio Ord (AVRO) | 0.1 | $17M | 1.0M | 16.26 | |
Clovis Oncology Note 1.250% 5/0 (Principal) | 0.1 | $12M | 19M | 0.62 | |
Nanostring Technologies (NSTGQ) | 0.1 | $11M | 350k | 30.35 | |
Eiger Biopharmaceuticals | 0.1 | $11M | 1.0M | 10.60 | |
Voya Financial (VOYA) | 0.1 | $10M | 185k | 55.30 | |
Veracyte (VCYT) | 0.1 | $10M | 350k | 28.51 | |
Phasebio Pharmaceuticals (PHASQ) | 0.1 | $9.9M | 757k | 13.12 | |
Twist Bioscience Corp (TWST) | 0.1 | $8.9M | 307k | 29.01 | |
Savara (SVRA) | 0.1 | $8.2M | 3.5M | 2.37 | |
Uniqure Nv SHS (QURE) | 0.1 | $7.8M | 100k | 78.15 | |
Milestone Pharmaceuticals (MIST) | 0.1 | $6.8M | 250k | 27.15 | |
Cyclerion Therapeutics | 0.1 | $6.2M | 544k | 11.45 | |
Solarcity Corp Note 1.625%11/0 (Principal) | 0.0 | $5.3M | 5.5M | 0.96 | |
Personalis Ord (PSNL) | 0.0 | $5.0M | 185k | 27.15 | |
Pfenex | 0.0 | $4.0M | 600k | 6.74 | |
Sanofi Right 12/31/2020 | 0.0 | $3.5M | 6.8M | 0.52 | |
Akero Therapeutics (AKRO) | 0.0 | $2.9M | 150k | 19.15 | |
Aptinyx | 0.0 | $2.2M | 670k | 3.34 | |
Gossamer Bio (GOSS) | 0.0 | $2.2M | 100k | 22.18 | |
Zafgen | 0.0 | $2.1M | 1.8M | 1.19 | |
Assembly Biosciences | 0.0 | $1.3M | 100k | 13.49 | |
Adaptive Biotechnologies Cor (ADPT) | 0.0 | $1.2M | 25k | 48.32 | |
Radius Health Note 3.000% 9/0 (Principal) | 0.0 | $1.1M | 1.3M | 0.91 | |
Occidental Petroleum Corporation (OXY) | 0.0 | $1.0M | 20k | 50.30 |